Cancer Summit

Nanotechnology and Drug Delivery Innovations in Cancer Therapy

Nanotechnology is revolutionizing cancer treatment by enabling highly precise drug delivery systems that improve therapeutic efficacy while minimizing toxicity to healthy tissues. Current trends focus on the development of nanoparticle-based carriers, liposomes, polymeric micelles, and nanoconjugates that can encapsulate chemotherapeutics, targeted agents, or biologics for controlled and tumor-specific release. These platforms enhance drug solubility, stability, and bioavailability, while facilitating passive targeting through the enhanced permeability and retention (EPR) effect or active targeting via tumor-specific ligands. Nanotechnology also supports combination therapies by co-delivering multiple agents to the tumor microenvironment, overcoming drug resistance, and improving treatment response. Advances in imaging-guided nanoparticles allow real-time monitoring of drug distribution, enabling personalized dosing strategies and precise therapeutic interventions. Emerging research explores multifunctional nanoplatforms for simultaneous therapy and diagnostics, termed “theranostics,” which integrate tumor detection, monitoring, and treatment in a single system. Challenges such as large-scale manufacturing, biocompatibility, regulatory approval, and cost-effectiveness remain critical for clinical translation. This session will explore the latest innovations in nanotechnology-driven drug delivery, preclinical and clinical applications, translational research, and the potential of nanomedicine to redefine the future of precision oncology and improve outcomes for cancer patients worldwide.